Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

16 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Long-term Outcomes of Peripheral Blood Stem Cell Unrelated Donors Mobilized with Filgrastim.
Stefanski HE, Kuxhausen M, Bo-Subait S, Kobusingye H, Mattila D, Schenfeld J, Sandschafer D, Burns LJ, Shaw BE, Pulsipher MA, Miller JP, Devine SM. Stefanski HE, et al. Among authors: kuxhausen m. Blood Adv. 2024 Apr 30:bloodadvances.2024012646. doi: 10.1182/bloodadvances.2024012646. Online ahead of print. Blood Adv. 2024. PMID: 38687368
Donor whole blood DNA methylation is not a strong predictor of acute graft versus host disease in unrelated donor allogeneic haematopoietic cell transplantation.
Webster AP, Ecker S, Moghul I, Liu X, Dhami P, Marzi S, Paul DS, Kuxhausen M, Lee SJ, Spellman SR, Wang T, Feber A, Rakyan V, Peggs KS, Beck S. Webster AP, et al. Among authors: kuxhausen m. Front Genet. 2024 Apr 3;15:1242636. doi: 10.3389/fgene.2024.1242636. eCollection 2024. Front Genet. 2024. PMID: 38633407 Free PMC article.
HLA Class I Genotype Is Associated with Relapse Risk after Allogeneic Stem Cell Transplantation for NPM1-Mutated Acute Myeloid Leukemia.
Narayan R, Niroula A, Wang T, Kuxhausen M, He M, Meyer E, Chen YB, Bhatt VR, Beitinjaneh A, Nishihori T, Sharma A, Brown VI, Kamoun M, Diaz MA, Abid MB, Askar M, Kanakry CG, Gragert L, Bolon YT, Marsh SGE, Gadalla SM, Paczesny S, Spellman S, Lee SJ. Narayan R, et al. Among authors: kuxhausen m. Transplant Cell Ther. 2023 Jul;29(7):452.e1-452.e11. doi: 10.1016/j.jtct.2023.03.027. Epub 2023 Mar 29. Transplant Cell Ther. 2023. PMID: 36997024
Corrigendum: Haplotype Motif-Based Models for KIR-Genotype Informed Selection of Hematopoietic Cell Donors Fail to Predict Outcome of Patients With Myelodysplastic Syndromes or Secondary Acute Myeloid Leukemia.
Schetelig J, Baldauf H, Koster L, Kuxhausen M, Heidenreich F, de Wreede LC, Spellman S, van Gelder M, Bruno B, Onida F, Lange V, Massalski C, Potter V, Ljungman P, Schaap N, Hayden P, Lee SJ, Kröger N, Hsu K, Schmidt AH, Yakoub-Agha I, Robin M. Schetelig J, et al. Among authors: kuxhausen m. Front Immunol. 2021 Dec 21;12:813838. doi: 10.3389/fimmu.2021.813838. eCollection 2021. Front Immunol. 2021. PMID: 34992613 Free PMC article.
Number of HLA-Mismatched Eplets Is Not Associated with Major Outcomes in Haploidentical Transplantation with Post-Transplantation Cyclophosphamide: A Center for International Blood and Marrow Transplant Research Study.
Zou J, Wang T, He M, Bolon YT, Gadalla SM, Marsh SGE, Kuxhausen M, Gale RP, Sharma A, Assal A, Prestidge T, Aljurf M, Cerny J, Paczesny S, Spellman SR, Lee SJ, Ciurea SO. Zou J, et al. Among authors: kuxhausen m. Transplant Cell Ther. 2022 Feb;28(2):107.e1-107.e8. doi: 10.1016/j.jtct.2021.11.001. Epub 2021 Nov 11. Transplant Cell Ther. 2022. PMID: 34774819 Free PMC article.
HLA informs risk predictions after haploidentical stem cell transplantation with posttransplantation cyclophosphamide.
Fuchs EJ, McCurdy SR, Solomon SR, Wang T, Herr MR, Modi D, Grunwald MR, Nishihori T, Kuxhausen M, Fingerson S, McKallor C, Bashey A, Kasamon YL, Bolon YT, Saad A, McGuirk J, Paczesny S, Gadalla SM, Marsh SGE, Shaw BE, Spellman SR, Lee SJ, Petersdorf EW. Fuchs EJ, et al. Among authors: kuxhausen m. Blood. 2022 Mar 10;139(10):1452-1468. doi: 10.1182/blood.2021013443. Blood. 2022. PMID: 34724567 Free PMC article.
Prognostic impact of pre-transplant chromosomal aberrations in peripheral blood of patients undergoing unrelated donor hematopoietic cell transplant for acute myeloid leukemia.
Wang Y, Zhou W, McReynolds LJ, Katki HA, Griffiths EA, Thota S, Machiela MJ, Yeager M, McCarthy P, Pasquini M, Wang J, Karaesmen E, Rizvi A, Preus L, Tang H, Wang Y, Pooler L, Sheng X, Haiman CA, Van Den Berg D, Spellman SR, Wang T, Kuxhausen M, Chanock SJ, Lee SJ, Hahn TE, Sucheston-Campbell LE, Gadalla SM. Wang Y, et al. Among authors: kuxhausen m. Sci Rep. 2021 Jul 22;11(1):15004. doi: 10.1038/s41598-021-94539-0. Sci Rep. 2021. PMID: 34294836 Free PMC article.
Genetics of HLA Peptide Presentation and Impact on Outcomes in HLA-Matched Allogeneic Hematopoietic Cell Transplantation.
Story CM, Wang T, Bhatt VR, Battiwalla M, Badawy SM, Kamoun M, Gragert L, Brown V, Baxter-Lowe LA, Marsh SGE, Gadalla SM, Schetelig J, Mytilineos J, Miklos D, Waller EK, Kuxhausen M, Spellman S, Lee S, Paczesny S, Lansford JL, Vincent BG, Riches ML, Armistead PM; Center for International Blood and Marrow Transplant Research Immunobiology Working Committee. Story CM, et al. Among authors: kuxhausen m. Transplant Cell Ther. 2021 Jul;27(7):591-599. doi: 10.1016/j.jtct.2021.04.003. Epub 2021 Apr 18. Transplant Cell Ther. 2021. PMID: 33882342 Free PMC article.
Impact of Previously Unrecognized HLA Mismatches Using Ultrahigh Resolution Typing in Unrelated Donor Hematopoietic Cell Transplantation.
Mayor NP, Wang T, Lee SJ, Kuxhausen M, Vierra-Green C, Barker DJ, Auletta J, Bhatt VR, Gadalla SM, Gragert L, Inamoto Y, Morris GP, Paczesny S, Reshef R, Ringdén O, Shaw BE, Shaw P, Spellman SR, Marsh SGE. Mayor NP, et al. Among authors: kuxhausen m. J Clin Oncol. 2021 Jul 20;39(21):2397-2409. doi: 10.1200/JCO.20.03643. Epub 2021 Apr 9. J Clin Oncol. 2021. PMID: 33835855 Free PMC article.
16 results